Wound Care Biologics Market Global Forecast 2024 | Key Vendors are Smith & Nephew, Integra LifeSciences, MiMedx, Wright Medical, Derma Sciences, Organogenesis Inc.

Rising elderly patient pool across the globe along with increasing prevalence of diabetes will act as major growth rendering factors for wound care biologics market growth. Globally, the around 415 million people were living with diabetes as of 2015 and the number is expected to reach 642 million by 2040 as per International Diabetes Federation (IDF). Age increases the risk of developing chronic diseases such as diabetes making the geriatric population more susceptible to chronic wounds. Furthermore, diabetes leads to complications such as ulcers in the lower extremity which are leading cause of disability and premature death. Such factors will propel demand for wound care biologics in the future.

Ask for full TOC of this report @ https://www.gminsights.com/request-toc/upcoming/2925

Increasing incidences of burn injuries is another significant growth impacting factor for wound care biologics market. Burns are the leading cause of injuries accounting for 5-12% of all the injuries occurring across the globe. Rising mortality associated with burn injuries will further increase demand for wound care biologics in the coming years. For instance, as per WHO, around 2,65,000 deaths occur due to burn injuries every year. Also, burn injuries pose a huge economic burden on the healthcare systems. Furthermore, rapid technological advancements for wound care management such as development of scaffolds, skin substitutes and bio-membranes will drive business market growth.

Favorable government initiatives for increasing awareness and stimulating adoption of wound care biologics will augment industry growth. For instance, ‘Heal Not Hurt’ campaign organized by wound care specialists along with Mölnlycke Health Care to spread awareness about pain and trauma associated with wounds. Also, The Wound Care Center at Canyon Vista Medical Center aims to raise awareness about diabetic foot ulcers among patients suffering from diabetes through National Diabetes Campaign. All such factors will spur demand for wound care biologics over the forecast timeline. However, high cost of wound care biologics resulting in unaffordability for patients in the developing countries would impede market growth.

Biological skin substitutes accounted for largest market share owing to increasing adoption of technology advanced tissue-engineered products to treat non-healing ulcers including diabetic foot ulcers and pressure ulcers. The biological skin substitutes are further segmented into acellular derived products, human donor derived products and biosynthetic products. Advantages offered by these skin substitutes such as reduced wound healing time, post-operative contracture, temporary or permanent wound closure will augment its demand over the coming years.

Based on the wound type, ulcers business segment dominated the wound care biologics market. Increasing prevalence of diabetes resulting into complications such as ulceration in the foot coupled with higher incidences of pressure ulcers among the geriatric patient pool will spur demand for biologics for effective wound care management and drive ulcers segment market growth. Rising incidences of burn injuries along with increasing traumatic events such as fire accidents will boost burns segment growth over the coming years.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2925

The various end-users of the wound care biologics include hospitals, ambulatory surgical centers, burn centers and wound clinics. Increasing usage of wound care biologics in the hospital settings for the treatment of ulcers, burns and accidents causing chronic wounds will propel hospitals segment market size.

U.S. wound care biologics market accounted for majority of the share owing to increasing incidences of burn injuries in the country. As per American Burn Association, more than 60% of the acute hospitalizations occur due to burn injuries. Also, around 200 patients are admitted per year in burn centers in the U.S. for effective treatment of burn injuries and skin disorders. Moreover, higher incidences of diabetic complications, presence of major industry players along with availability of wound care biologics in the country will boost overall North America industry growth.

Asia Pacific wound care biologics market will grow at a rapid pace over the forecast period. Higher incidences of burn injuries in the Asian countries will drive regional industry growth. For instance, according to WHO, more than 96% of the fatal fire-related burns occurs in low- and middle-income countries. Moreover, presence of huge diabetic and geriatric population in the developing countries such as China and India will boost drive Asia Pacific wound care biologics market growth.

Some of the key industry players operating in the global wound care biologics market include Mölnlycke Health Care, Smith & Nephew, Integra Lifesciences, Mimedx Group, Organogenesis, Wright Medical, Osiris Therapeutics, Vericel, Derma Sciences, Kerecis, Amnio Technology, Solsys Medical, Acell, Marine Polymer Technologies and Skye Biologics. The market players focus on research and development activities to develop novel products for effective treatment of chronic wounds.

About Global Market Insights
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com

This release was published on openPR.